You are here

Cetya Therapeutics, Inc.

Company Information
4605 Valley Ridge Ct
Fort Collins, CO 80526-6500
United States



# of Employees: 3

Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts

Award Listing

  1. In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders

    Amount: $1,073,855.00

    PROJECT SUMMARY The β-hemoglobinopathies are prevalent genetic blood diseases with few treatment options. It is estimate that 7% of the worldandapos;s population carries an abnormal hemoglobin gene w ...

    STTRPhase II2019Department of Health and Human Services National Institutes of Health
  2. Novel HDAC Inhibitors for Treatment of Hemoglobinopathies

    Amount: $241,742.00

    Project Summary Induction of normal but developmentally silenced fetal globin expression reduces anemia and ameliorates clinical severity in the beta hemoglobinopathies HDACs and are compon ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government